Liver toxicity in the Phase 2 Catalyst 206 trial of Inarigivir 400 mg daily added to a nucleoside in HBV EAg negative patientsKosh Agarwal,Nezam Afdhal,Carla Coffin,Scott Fung,Geoffrey Dusheiko,Graham Foster,Magdy Elkhashab,Edward Tam,Alnoor Ramji,Radhakrishnan Iyer,Patrick KennedyJournal of Hepatology(2020)引用 7|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要